Epigenetic Impact of Long-Term Shiftwork: Pilot Evidence From Circadian Genes and Whole-Genome Methylation Analysis

REFERENCES

• Bai Z, Gust R. (2009). Breast cancer, estrogen receptor and ligands. Arch. Pharm. (Weinheim) 342:133–149.
   PubMed Web of Science ®Google Scholar
• Bollati V, Baccarelli A, Sartori S, Tarantini L, Motta V, Rota F, Costa G .(2010). Epigenetic effects of shiftwork on blood DNA methylation. Chronobiol. Int. 27:1093–1094.
   PubMed Web of Science ®Google Scholar
• Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF. (2005). A network-based analysis of systemic inflammation in humans. Nature 437:1032–1037.
   PubMed Web of Science ®Google Scholar
• Celebiler Cavusoglu A, Sevinc AI, Saydam S, Canda T, Baskan Z, Kilic Y, Sakizli M. (2010). Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue. Neoplasma 57:465–472.
   PubMed Web of Science ®Google Scholar
• Hansen J. (2010). Women with night shift work and breast cancer: the situation in Denmark. J. Epidemiol. Community Health 64(12):1025–1026.
   Google Scholar
• Hoffman AE, Yi CH, Zheng T, Stevens RG, Leaderer D, Zhang Y, Holford TR, Hansen J, Paulson J, Zhu Y. (2010a). CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res. 70:1459–1468.
   PubMed Web of Science ®Google Scholar
• Hoffman AE, Zheng T, Yi CH, Stevens RG, Ba Y, Zhang Y, Leaderer D, Holford T, Hansen J, Zhu Y. (2010b). The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev. Res. (Phila. Pa.) 3:539–548.
   PubMed Web of Science ®Google Scholar
• Kang TH, Lindsey-Boltz LA, Reardon JT, Sancar A. (2010). Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase. Proc. Natl. Acad. Sci. U. S. A. 107:4890–4895.
   PubMed Web of Science ®Google Scholar
• Kim YI. (2004). Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol. Biomarkers Prev. 13:511–519.
   PubMed Web of Science ®Google Scholar
• Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H. (2007). Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res. 67:10117–10122.
   PubMed Web of Science ®Google Scholar
• Overvad K, Tjonneland A, Haraldsdottir J, Ewertz M, Jensen OM. (1991). Development of a semiquantitative food frequency questionnaire to assess food, energy and nutrient intake in Denmark. Int. J. Epidemiol. 20:900–905.
   PubMed Web of Science ®Google Scholar
• Parrella P, Poeta ML, Gallo AP, Prencipe M, Scintu M, Apicella A, Rossiello R, Liguoro G, Seripa D, Gravina C, Rabitti C, Rinaldi M, Nicol T, Tommasi S, Paradiso A, Schittulli F, Altomare V, Fazio VM. (2004). Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin. Cancer Res. 10:5349–5354.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911–1929.
   PubMed Web of Science ®Google Scholar
• Ruike Y, Imanaka Y, Sato F, Shimizu K, Tsujimoto G. (2010). Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics 11:137.
   Google Scholar
• Stevens RG. (1987). Electric power use and breast cancer: a hypothesis. Am. J. Epidemiol. 125:556–561.
   PubMed Web of Science ®Google Scholar
• Stevens RG. (2009). Electric light causes cancer? Surely you're joking, Mr. Stevens. Mutat. Res. 682:1–6.
   PubMed Web of Science ®Google Scholar
• Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW. (1992). Electric power, pineal function, and the risk of breast cancer. FASEB J. 6:853–860.
   PubMed Web of Science ®Google Scholar
• Straif K, Baan R, Grosse Y, Secreton B, El Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L, Cogliano V. (2007). Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 8:1065–1066.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Chen YY, Scott GK, Devries S, Chin K, Benz CC, Waldman FM, Hwang ES. (2009). Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression. Clin. Cancer Res. 15:3163–3171.
   PubMed Web of Science ®Google Scholar
• Tjonneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, Overvad K. (2007). Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand. J. Public Health 35:432–441.
   PubMed Web of Science ®Google Scholar
• Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, Stegmaier C, Jacobs IJ, Brenner H. (2008). Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS ONE 3:e2656.
   Google Scholar
• Zhu Y, Brown HN, Zhang Y, Holford TR, Zheng T. (2005). Genotypes and haplotypes of the methyl-CpG-binding domain 2 modify breast cancer risk dependent upon menopausal status. Breast Cancer Res. 7:R745–R752.
   PubMed Web of Science ®Google Scholar